83 related articles for article (PubMed ID: 26074357)
1. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.
Fujita Y; Kojima T; Kawakami K; Mizutani K; Kato T; Deguchi T; Ito M
Prostate; 2015 Oct; 75(14):1568-78. PubMed ID: 26074357
[TBL] [Abstract][Full Text] [Related]
2. microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1.
Chen X; Zhao M; Huang J; Li Y; Wang S; Harrington CA; Qian DZ; Sun XX; Dai MS
J Cell Biochem; 2018 Jun; 119(6):4945-4956. PubMed ID: 29384218
[TBL] [Abstract][Full Text] [Related]
3. Exploiting epigenetic targets to overcome taxane resistance in prostate cancer.
Cevatemre B; Bulut I; Dedeoglu B; Isiklar A; Syed H; Bayram OY; Bagci-Onder T; Acilan C
Cell Death Dis; 2024 Feb; 15(2):132. PubMed ID: 38346967
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and Noncoding RNAs in Taxane Resistance.
Pucci P; Rescigno P; Sumanasuriya S; de Bono J; Crea F
Trends Pharmacol Sci; 2018 Aug; 39(8):695-709. PubMed ID: 29891252
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor A blockade enhances taxane effects in prostate cancer.
Akhavan A; McHugh KH; Guruli G; Bies RR; Zamboni WC; Strychor SA; Nelson JB; Pflug BR
Neoplasia; 2006 Sep; 8(9):725-32. PubMed ID: 16984730
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.
Wang JQ; DeChalus A; Chatterjee DN; Keller ET; Mizokami A; Camussi G; Mendelsohn AR; Renzulli Ii JF; Quesenberry PJ; Chatterjee D
Crit Rev Oncog; 2015; 20(5-6):407-17. PubMed ID: 27279238
[TBL] [Abstract][Full Text] [Related]
7. The determination of changes in the expression of genes for selected specific transcriptional factors in in vitro ductal breast cancer cells under the influence of paclitaxel.
Ziaja-Sołtys M; Rzymowska J
Cell Mol Biol Lett; 2011 Dec; 16(4):610-24. PubMed ID: 21909792
[TBL] [Abstract][Full Text] [Related]
8. MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells.
Tohidast M; Memari N; Amini M; Hosseini SS; Jebelli A; Doustvandi MA; Baradaran B; Mokhtarzadeh A
Iran J Basic Med Sci; 2023; 26(11):1350-1359. PubMed ID: 37886001
[TBL] [Abstract][Full Text] [Related]
9. Heterologous expression of taxane genes confers resistance to fall armyworm in Nicotiana benthamiana.
Xu Z; Zhai Y; Chang H; Yan D; Ge P; Ren G; Zhang L; Yuan Y; Wang R; Li W; Li F; Ren M; Mo H
Plant Cell Rep; 2024 Mar; 43(4):94. PubMed ID: 38472660
[TBL] [Abstract][Full Text] [Related]
10. P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane.
Hassan MK; Watari H; Mitamura T; Mohamed Z; El-Khamisy SF; Ohba Y; Sakuragi N
Oncoscience; 2015; 2(3):294-308. PubMed ID: 25897432
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia.
Cui YL; Wang B; Gao HM; Xing YH; Li J; Li HJ; Lin Z; Wang YQ
Patient Prefer Adherence; 2016; 10():313-9. PubMed ID: 27042022
[TBL] [Abstract][Full Text] [Related]
12. miR-130a activates the VEGFR2/STAT3/HIF1α axis to potentiate the vasoregenerative capacity of endothelial colony-forming cells in hypoxia.
Guduric-Fuchs J; Pedrini E; Lechner J; Chambers SEJ; O'Neill CL; Mendes Lopes de Melo J; Pathak V; Church RH; McKeown S; Bojdo J; Mcloughlin KJ; Stitt AW; Medina RJ
Mol Ther Nucleic Acids; 2021 Mar; 23():968-981. PubMed ID: 33614244
[TBL] [Abstract][Full Text] [Related]
13. VEGF-activated miR-144 regulates autophagic survival of prostate cancer cells against Cisplatin.
Liu F; Wang J; Fu Q; Zhang X; Wang Y; Liu J; Huang J; Lv X
Tumour Biol; 2015 Nov; ():. PubMed ID: 26566625
[TBL] [Abstract][Full Text] [Related]
14. miR-130a inhibits cell viability and migration through FOSL1 in lung cancer.
Xu Y; Wang L; Liu J
J Biol Regul Homeost Agents; 2020 Apr; 34(2):. PubMed ID: 32351101
[No Abstract] [Full Text] [Related]
15. Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.
Luo Y; Jiang QW; Wu JY; Qiu JG; Zhang WJ; Mei XL; Shi Z; Di JM
Oncotarget; 2015 Sep; 6(26):22564-74. PubMed ID: 26087186
[TBL] [Abstract][Full Text] [Related]
16. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract][Full Text] [Related]
17. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer.
Kitagawa Y; Ueno S; Izumi K; Kadono Y; Mizokami A; Hinotsu S; Akaza H; Namiki M
World J Urol; 2016 Mar; 34(3):319-27. PubMed ID: 26089252
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer.
Litovkin K; Van Eynde A; Joniau S; Lerut E; Laenen A; Gevaert T; Gevaert O; Spahn M; Kneitz B; Gramme P; Helleputte T; Isebaert S; Haustermans K; Bollen M
PLoS One; 2015; 10(6):e0130651. PubMed ID: 26086362
[TBL] [Abstract][Full Text] [Related]
20. Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer.
Hoare D; Skinner TA; Black A; Robert Siemens D
Can Urol Assoc J; 2015; 9(3-4):122-7. PubMed ID: 26085869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
